This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Masahiro Tsuboi: Innovator in Lung Cancer Treatment
Introduction
Masahiro Tsuboi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of oncology, particularly in the treatment of lung cancer. His innovative approach has the potential to improve the quality of life for patients undergoing postoperative care.
Latest Patents
Tsuboi holds a patent for a method titled "Postoperative adjuvant chemotherapy with UFT." This invention provides an improved method for treating lung cancer, specifically non-small cell lung cancer, by orally administering UFT to postoperative lung cancer patients. This advancement represents a crucial step in enhancing treatment efficacy and patient outcomes.
Career Highlights
Masahiro Tsuboi is associated with Taiho Pharmaceutical Company Limited, where he has been instrumental in developing new therapeutic strategies. His work focuses on improving cancer treatment protocols and ensuring better patient care.
Collaborations
Tsuboi has collaborated with notable colleagues, including Mitsuo Ohta and Hiromi Wada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of cancer research.
Conclusion
Masahiro Tsuboi's contributions to lung cancer treatment through his patent and work at Taiho Pharmaceutical Company Limited highlight his dedication to improving patient outcomes. His innovative methods are paving the way for advancements in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile